Filing Details
- Accession Number:
- 0000908662-14-000110
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-06 17:26:34
- Reporting Period:
- 2014-03-05
- Filing Date:
- 2014-03-06
- Accepted Time:
- 2014-03-06 17:26:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
907562 | Dyax Corp | DYAX | Services-Commercial Physical & Biological Research (8731) | 043053198 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1436861 | Paolo Pucci | C/O Dyax Corp. 55 Network Drive Burlington MA 01803-2756 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-03-05 | 25,000 | $1.35 | 25,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-03-05 | 20,000 | $10.31 | 5,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2014-03-05 | 25,000 | $0.00 | 25,000 | $1.35 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2021-11-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $10.30 to $10.41, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.
- Options became fully vested as of May 9, 2012.